Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 15 citing Mastorikou: Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes. (0.09 sec) 

Why is HDL functionally deficient in type 2 diabetes?


A Kontush, MJ Chapman - Current Diabetes Reports, 2008 - Springer
High-density lipoprotein (HDL) particles exert a spectrum of atheroprotective activities that can
be deficient in type 2 diabetes. Key mechanisms leading to the formation of functionally deficient
HDL involve 1) HDL enrichment in triglycerides and depletion in cholesteryl esters with ...
Cited by 12 - Related articles - BL Direct - All 2 versions

Paraoxonase 1 (PON1) attenuates diabetes development in mice through its …


O Rozenberg, M Shiner, M Aviram, T Hayek - Free Radical Biology and …, 2008 - Elsevier
Paraoxonase 1 (PON1) is a lipo-lactonase which is associated with HDL and possesses antioxidative
properties. Diabetes is characterized by increased oxidative stress and by decreased PON1
activity. We aimed to analyze whether oxidative status and PON1 levels in mouse sera ...
Cited by 11 - Related articles - All 2 versions

Targets for intervention in dyslipidemia in diabetes


GH Tomkin - Diabetes care, 2008 - Am Diabetes Assoc
Treatment for dyslipidemia in diabetes reduces cardiovascular events. Diabetes is associated
with major abnormalities in fatty acid metabolism. The resulting disturbance results in an abnormal
lipoprotein cascade from the large chylomicron through to the small HDL particle. This ...
Cited by 6 - Related articles - BL Direct - All 6 versions

Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS


AM Wills, JE Landers, H Zhang, RJ Richter, AJ … - Neurology, 2008 - AAN Enterprises
From the Day Neuromuscular Research Laboratory, Department of Neurology (A.-MW, JEL,
RHB), Biostatistics Center (HZ), and Neurology Clinical Trials Unit, Department of Neurology
(AJC, MEC), Massachusetts General Hospital, Harvard Medical School, Boston, MA; and ...
Cited by 7 - Related articles - All 5 versions

The paraoxonases: role in human diseases and methodological difficulties in …


J Camps, J Marsillach, J Joven - Critical Reviews in Clinical …, 2009 - informahealthcare.com
Research into the paraoxonase (PON) gene family has flourished over the past few years. In
the 1970s and 1980s, only PON1 was known, and the investigations were conducted,
essentially, by toxicologists focusing on protection against organophosphate poisoning. ...
Cited by 7 - Related articles - All 6 versions

High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) …


RPF Dullaart, R de Vries, WJ Sluiter, HAM … - Clinical …, 2009 - nursing2008.com
Objectives: In type 2 diabetes mellitus, circulating C-reactive protein (CRP) is increased, whereas
the high density lipoprotein (HDL)-associated, anti-oxidative and anti-inflammatory enzyme,
paraoxonase-I, is decreased. Both high CRP and low paraoxonase-I activity may predict ...
Cited by 4 - Related articles - Cached - All 5 versions

Paraoxonases role in the prevention of cardiovascular diseases


M Rosenblat, M Aviram - Biofactors, 2009 - interscience.wiley.com
Increased oxidative stress is a characteristic of patients with high risk for atherosclerosis development
(hypercholesterolemic, hypertensive, diabetic), and the above phenomenon was shown to be
associated with attenuated antioxidative status. The increased oxidative stress in ...
Cited by 2 - Related articles - All 2 versions

Oxidized LDL and the metabolic syndrome

- nih.gov
P Holvoet, D De Keyzer, DR Jacobs Jr - Future Lipidol., 2008 - Future Medicine
The metabolic syndrome is a common and complex disorder combining obesity,
dyslipidemia, hypertension and insulin resistance. It is associated with a high cardiovascular
risk that can only partially be explained by its components. There is evidence that ...
Cited by 1 - Related articles - All 18 versions

HDL-replacement therapy: mechanism of action, types of agents and potential …


AT Remaley, M Amar, D Sviridov - Expert Review of Cardiovascular …, 2008 - ingentaconnect.com
It has been over 50 years since the respective pro- and anti-atherogenic effects of LDL and HDL
were first described [1] , but the main focus has been on developing agents for decreasing
LDL- cholesterol (LDL-C). There is now great interest in identifying new agents for raising ...
Cited by 1 - Related articles - All 9 versions

[CITATION] Genetic Polymorphism in Paraoxonase 1 (PON1): Population Distribution of PON1 …


G Ginsberg, P Neafsey, D Hattis, KZ Guyton, … - Journal of Toxicology …, 2009 - Taylor & Francis
Related articles


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google